Tags
Subscribe
Subscribe
News
Schools
Business
Obituaries
Police & Fire
Weather
Neighbors
Lifestyle
Politics
Sports
Events
Traffic
Legal
Real Estate
Tags
Jobs
Shop
Support Us
Subscribe
News
Schools
Business
Obituaries
Police & Fire
Weather
Neighbors
Lifestyle
Politics
Sports
Events
Traffic
Legal
Real Estate
Readers Choice
Tags
Jobs
Shop
Support Us
Home
About us
All sites
Advertise with us
Contact us
Terms of use
Privacy policy
Code of ethics
Site Map
© 2026 Cantata Media
Massapequa, NY
News
Covid-
19: Long Island Sees New Infection-Rate Increase; New Breakdown By Community
Some of New York's 10 regions are showing some signs of improving COVID-19 numbers, though Long Island isn't one of them as the number of new infections continues to rise due to variants of the virus. According to the Department of Health, the two-week surge of new cases of Long Island continued, with the infection rate jumping to 3.37 percent of those tested, up from under 3 percent as recently as Saturday, July 31. The infection rate is the second-highest of the state's 10 regions. Statewide, the positive infection rate jumped from 2.46 percent to 2.74 percent in that same time fra…
Massapequa, NY
News
Covid-
19: Long Island Infection Rate Increases Again; Latest Breakdown By Community
The Delta variant continues to run wild throughout New York as the COVID-19 positive infection rate on Long Island continues to rise, up near 2 percent. According to the Department of Health, the positive-testing rate for those tested on Long Island has hit 1.97 percent as of Thursday, July 22, up from approximately 1 percent less than two weeks ago. There were no new virus-related deaths on Long Island in the past 24 hours, though a single fatality was reported in Erie County. Infection rates in the state’s 10 regions on July 22, according to the state Department of Health: Capital Regi…
White Plains, NY
News
Covid-
19: Concerns Over Delta Variant Grow As US Cases Double In Three Weeks
While much of the country is settling into the “new normal” following the rise and fall of the COVID-19 crisis, the Delta variant is proving to be the one variable Americans still have to contend with. Concerns are rising across the country about the variant after the US has seen a spike in daily COVID-19 cases from approximately 11,300 in late June to nearly 24,000 as of Monday, July 12, according to Johns Hopkins University. According to health officials, the reason for the rise in cases is largely due to the Delta variant, which now makes up the majority of new COVID-19 infections, large…
Massapequa, NY
News
Covid-
19: Mixed Messaging About Booster Shots From CDC, Pfizer Causing Confusion
Pfizer has announced plans to submit data on a COVID-19 booster vaccine it is developing to regulatory agencies in the coming weeks. However, the Centers for Disease Control and Prevention and the Food and Drug Administration are pushing back, saying booster vaccines are not needed at this time. Confused? You're not alone. On Thursday, July 8, Pfizer and European partner BioNTech said in a news release that the companies are working on a third vaccine dose to combat COVID-19 and its variants, including the Delta variant. The companies said they expect clinical studies will begin in A…
Massapequa, NY
News
Covid-
19: New York's State Of Emergency To Be Lifted
The State of Emergency put in place in New York more than a year ago is set to expire as the state continues its recovery from the COVID-19 pandemic. New York Gov. Andrew Cuomo announced that as of Thursday, June 24, the State of Emergency will be lifted as the state went from one of the COVID-19 hotbeds in the world to the lowest infection rate in the country. “The State of Emergency expires tomorrow, and it will not be renewed,” Cuomo said during a COVID-19 briefing in Manhattan on Wednesday, June 23. “It will punctuate the end of the emergency we’ve been in because New Yorkers and essent…
Torrington, CT
News
Covid-
19: Moderna Asks FDA To Approve Vaccines For Those Ages 12 To 17
Moderna has requested an emergency use authorization from the Food and Drug Administration (FDA) for its COVID-19 vaccine in adolescents between the ages of 12 and 17. The company announced that clinical trials have shown that the vaccine has a 93 percent efficacy rate among adolescents, and has been proven to be safe. If approved, it would be the second COVID-19 vaccine authorized for adolescents, joining the Pfizer-BioNTech vaccine, which was given the green light for use earlier this month. In their study, Moderna found no cases of COVID-19 in participants who received two doses of th…
Kingston, NY
News
Covid-
19: Vaccine 'Safe, Highly Effective' In Kids 12-17, Moderna Says, Will Seek FDA Approval
Moderna’s COVID-19 vaccine has proven effective and safe for adolescents and teens between the ages of 12 and 17, the company announced, as it prepares to seek federal authorization. The company announced that clinical trials have shown that the vaccine has a 93 percent efficacy rate among adolescents, and has been proven to be safe. Moderna officials said that they plan to apply for federal approval from the Food and Drug Administration (FDA) to use the vaccine in that age group in June. If approved, it would be the second COVID-19 vaccine authorized for adolescents, joining the Pfizer-Bi…
Lewisboro, NY
News
Covid-
19: New Time Frame Provided For When Vaccine Booster Shots May Be Necessary
Executives and experts at the center of COVID-19 pandemic response are now providing a more specific possible time frame for when Americans who were first to receive a vaccine dose may need to take a booster shot. Pfizer CEO Albert Bourla, speaking during an Axios event, said that the data he has reviewed supports the notion "that likely there will be a need for a booster somewhere between eight and 12 months" after the initial vaccination regime. That means those who were among the first to get a vaccine shot in mid to late December 2020 or early January 2021 would likely need a booster sh…
Lower Paxton, PA
News
PA Gov. Tom Wolf Extends Proclamation of Disaster Despite Vote To Limit This Ability
Pennsylvania Gov. Tom Wolf signed a renewal of the Proclamation of Disaster Emergency for the COVID-19 pandemic on Thursday, according to his office. The fifth renewal of the disaster emergency comes just two days after voters in the Keystone state approved a constitutional amendment to limit the governor's emergency powers. The amendment will require any governor of the state to receive approval from the legislature to extend any public emergency declaration beyond 21 days. The vote has yet to be certified by the state. The first proclamation was signed on March 6, 2020. The extension …
White Plains, NY
News
Covid-
19: Pfizer Seeks Federal Approval To Market Vaccine Directly To Consumers
Pfizer and European partner company BioNTech are seeking full approval from the federal government to market their two-dose COVID-19 vaccine directly to people age 16 and over, as well as businesses and schools. The vaccine has been available in the United States since mid-December under an Emergency Use Authorization waiver by the Food and Drug Administration. Since then, the companies have delivered more than 170 million doses of the vaccine across the United States. “We are proud of the tremendous progress we’ve made since December in delivering vaccines to millions of Americans, in col…
Harrison, NY
News
Covid-
19: Stop & Shop Now Offering Same-Day Vaccinations
Stop & Shop has become the latest to begin offering walk-in, same-day COVID-19 vaccines. In an effort to expand vaccination efforts, the grocery giant announced that it has the supply to begin offering either the two-dose Moderna or one-shot Johnson & Johnson vaccine at its more than 250 pharmacies to all eligible customers. Customers can still schedule an appointment online, but they are no longer required to receive an immunization. Anyone who gets a first dose of Moderna will have their second appointment scheduled on location following the administration of the shot. Related …
Hamilton Township, NJ
News
Covid-
19: Pfizer Nearing Release Of Vaccine For Children Ages 12 -15, FDA Says
The U.S. Food and Drug Administration could authorize Pfizer-BioNTech's coronavirus vaccine for children ages 12 to 15 as early as next week, the New York Times reported on Monday, citing federal officials. The timing could not be better for school districts that are resuming in-person instruction and hoping for a full return to normalcy next fall. Vaccinating children is also a crucial element in achieving heard immunity and decreasing numbers of hospitalizations and deaths, The Times says. While NJ, NY and CT positive rates have been dropping, other states including Pen…
Next Page
Archive
